Nathues H, Alarcon P, Rushton J, Jolie R, Fiebig K, Jimenez M, et al. Modelling the economic efficiency of using different strategies to control porcine reproductive & respiratory syndrome at herd level. Prev Vet Med. 2018;152:89–102.
Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. Javma-J Am Vet Med A. 2005;227(3):385–92.
Renken C, Nathues C, Swam H, Fiebig K, Weiss C, Eddicks M, et al. Application of an economic calculator to determine the cost of porcine reproductive and respiratory syndrome at farm-level in 21 pig herds in Germany. Porcine Health Manag. 2021;7(1):3.
Valdes-Donoso P, Alvarez J, Jarvis LS, Morrison RB, Perez AM. Production losses from an endemic animal disease: porcine reproductive and respiratory syndrome (PRRS) in selected Midwest US sow farms. Front Vet Sci. 2018;5:102.
Vilalta C, Arruda AG, Tousignant SJP, Valdes-Donoso P, Muellner P, Muellner U, et al. A Review of quantitative tools used to assess the epidemiology of porcine reproductive and respiratory syndrome in U.S. swine farms using Dr. Morrison’s swine health monitoring program data. Front Vet Sci. 2017;4:94.
Ruedas-Torres I, Sanchez-Carvajal JM, Salguero FJ, Pallares FJ, Carrasco L, Mateu E, et al. The scene of lung pathology during PRRSV-1 infection. Front Vet Sci. 2024;11:1330990.
Collins JE, Benfield DA, Christianson WT, Harris L, Hennings JC, Shaw DP, et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J Vet Diagn Invest. 1992;4(2):117–26.
Bai YZ, Sun Y, Liu YG, Zhang HL, An TQ, Wang Q, et al. Minor envelope proteins from GP2a to GP4 contribute to the spread pattern and yield of type 2 PRRSV in MARC-145 cells. Front Cell Infect Microbiol. 2024;14:1376725.
Gao F, Jiang YF, Li GX, Zhou YJ, Yu LX, Li LW, et al. Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV. Vaccine. 2018;36(23):3269–77.
Dokland T. The structural biology of PRRSV. Virus Res. 2010;154(1–2):86–97.
Mardassi H, Gonin P, Gagnon CA, Massie B, Dea S. A subset of porcine reproductive and respiratory syndrome virus GP glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form. J Virol. 1998;72(8):6298–306.
Sun Q, Yu X, He D, Ku X, Hong B, Zeng W, et al. Investigation and analysis of etiology associated with porcine respiratory disease complex in China from 2017 to 2021. Front Vet Sci. 2022;9: 960033.
Wang G, Zhu H, Zhan C, Chen P, Wu B, Peng Z, et al. Establishment and application of a quadruplex real-time reverse-transcription polymerase chain reaction assay for differentiation of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, porcine circovirus type 3, and streptococcus suis. Microorganisms. 2024;12(3):427.
D’Annunzio G, Ostanello F, Muscatello LV, Orioles M, Jacumin N, Tommasini N, et al. Porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus alone or associated are frequent intralesional detected viruses in porcine respiratory disease complex cases in Northern Italy. Front Vet Sci. 2023;10:1234779.
Drolet R, Larochelle R, Morin M, Delisle B, Magar R. Detection rates of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and swine influenza virus in porcine proliferative and necrotizing pneumonia. Vet Pathol. 2003;40(2):143–8.
Fan PH, Wei YW, Guo LJ, Wu HL, Huang LP, Liu JB, et al. Synergistic effects of sequential infection with highly pathogenic porcine reproductive and respiratory syndrome virus and porcine circovirus type 2. Virol J. 2013;10:265.
Harms PA, Sorden SD, Halbur PG, Bolin SR, Lager KM, Morozov I, et al. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet Pathol. 2001;38(5):528–39.
Kong C, Li D, Hu Y, Gao P, Zhang Y, Zhou L, et al. The genetic variation of porcine reproductive and respiratory syndrome virus replicase protein nsp2 modulates viral virulence and persistence. J Virol. 2023;97(3): e0168922.
Pileri E, Mateu E. Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination. Vet Res. 2016;47(1):108.
Qiu H, Sun M, Wang N, Zhang S, Deng Z, Xu H, et al. Efficacy comparison in cap VLPs of PCV2 and PCV3 as swine vaccine vehicle. Int J Biol Macromol. 2024;278(Pt 3): 134955.
Wang Y, Xu F, Yuan C, Zhang Y, Ren J, Yue H, et al. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells. Vaccine. 2024;42(11):2848–57.
Gao YY, Wang Q, Li HW, Zhang S, Zhao J, Bao D, et al. Genomic composition and pathomechanisms of porcine circoviruses: a review. Virulence. 2024;15(1):2439524.
Park C, Seo HW, Park SJ, Han K, Chae C. Comparison of porcine circovirus type 2 (PCV2)-associated lesions produced by co-infection between two genotypes of PCV2 and two genotypes of porcine reproductive and respiratory syndrome virus. J Gen Virol. 2014;95(Pt 11):2486–94.
Morales-Hernandez S, Ugidos-Damboriena N, Lopez-Sagaseta J. Self-assembling protein nanoparticles in the design of vaccines: 2022 update. Vaccines (Basel). 2022;10(9):1447.
Ziqi W, Kai C, Costabel U, Xiaoju Z. Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemic. Exploration (Beijing). 2022;2(5):20210082.
Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater. 2011;10(3):243–51.
Lopez-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J. 2016;14:58–68.
Sanchooli A, Aghaiypour K, Kiasari BA, Samarbaf-Zadeh A, Ghadiri A, Makvandi M. VLP production from recombinant L1/L2 HPV-16 protein expressed in Pichia pastoris. Protein Pept Lett. 2018;25(8):783–90.
Yadav R, Zhai L, Tumban E. Virus-like particle-based L2 vaccines against HPVs: where are we today? Viruses. 2019;12(1):18.
Roldao A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines. 2010;9(10):1149–76.
Hemmati F, Hemmati-Dinarvand M, Karimzade M, Rutkowska D, Eskandari MH, Khanizadeh S, et al. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2. Biotechnol Lett. 2022;44(1):45–57.
Li RQ, Chang ZJ, Liu HL, Wang YN, Li MH, Chen YL, et al. Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2. J Nanobiotechnol. 2024;22(1):44.
Jung BK, Kim HR, Lee YH, Jang H, Chang KS. Comparison of immune responses to the PCV2 replicase-capsid and capsid virus-like particle vaccines in mice. J Microbiol Biotechnol. 2019;29(3):482–8.
Lin HX, Ma Z, Hou X, Chen L, Fan HJ. Construction and immunogenicity of a recombinant swinepox virus expressing a multi-epitope peptide for porcine reproductive and respiratory syndrome virus (vol 7, pg 43990, 2017). Sci Rep-Uk. 2017;7:46592.
Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, et al. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine. 2006;24(15):2869–79.
Ma H, Li X, Li J, Zhao Z, Zhang H, Hao G, et al. Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs. Virology. 2021;552:112–20.
Ren JQ, Sun WC, Lu HJ, Wen SB, Jing J, Yan FL, et al. Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus. BMC Vet Res. 2014;10:128.
Xu XG, Wang ZS, Zhang Q, Li ZC, Ding L, Li W, et al. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: Baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2. J Virol Methods. 2012;179(2):359–66.
Zhu S, Guo X, Keyes LR, Yang HC, Ge XN. Recombinant encephalomyocarditis viruses elicit neutralizing antibodies against PRRSV and CSFV in mice. PLoS ONE. 2015;10(6): e0129729.
Piñeyro PE, Kenney SP, Giménez-Lirola LG, Heffron CL, Matzinger SR, Opriessnig T, et al. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV. Virus Res. 2015;210:154–64.
Hu GW, Wang ND, Yu WT, Wang ZF, Zou YW, Zhang Y, et al. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B. Vaccine. 2016;34(16):1896–903.
Li GP, Liu L, Xu BJ, Hu JX, Kuang HY, Wang X, et al. Displaying epitope B and epitope 7 of porcine reproductive and respiratory syndrome virus on virus like particles of porcine circovirus type 2 provides partial protection to pigs. J Vet Med Sci. 2021;83(8):1263–72.
Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol. 2002;76(13):6863.
Kang SJ, Bae SM, Lee HJ, Jeong YJ, Lee MA, You SH, et al. Porcine circovirus (PCV) genotype 2d-based virus-like particles (VLPs) Induced broad cross-neutralizing antibodies against diverse genotypes and provided protection in dual-challenge infection of a PCV2d virus and a type 1 porcine reproductive and respiratory syndrome virus (PRRSV). Pathogens. 2021;10(9):1145.
Lamazares E, Gutiérrez F, Hidalgo A, Gutiérrez NA, Espinoza FI, Sánchez O, et al. A heterologous viral protein scaffold for chimeric antigen design: an example PCV2 virus vaccine candidate. Viruses-Basel. 2020;12(4):385.
Li X, Meng XP, Wang SN, Li ZQ, Yang L, Tu LQ, et al. Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses. Appl Microbiol Biot. 2018;102(24):10541–50.
Zhang HW, Qian P, Liu LF, Qian SH, Chen HC, Li XM. Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes. Viruses-Basel. 2014;6(12):4839–55.
Li B, Xiao SB, Wang YW, Xu SS, Jiang YB, Chen HC, et al. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene. Vaccine. 2009;27(13):1957–63.
Li DG, Wang J, Xu SG, Cai SX, Ao CJ, Fang LR, et al. Identification and functional analysis of the novel ORF6 protein of porcine circovirus type 2. Vet Res Commun. 2018;42(1):1–10.
Mirdita M, Schutze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19(6):679–82.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9.
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–303.
Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, et al. The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Res. 2017;45(D1):D313–9.
Khayat R, Brunn N, Speir JA, Hardham JM, Ankenbauer RG, Schneemann A, et al. The 2.3-angstrom structure of porcine circovirus 2. J Virol. 2011;85(21):11542.
Xue CY, Wang W, Liu QL, Miao ZW, Liu K, Shen HF, et al. Chimeric influenza-virus-like particles containing the porcine reproductive and respiratory syndrome virus GP5 protein and the influenza virus HA and M1 proteins. Arch Virol. 2014;159(11):3043–51.
Fort M, Olvera A, Sibila M, Segales J, Mateu E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet Microbiol. 2007;125(3–4):244–55.
Sun YY, Gao YN, Su TJ, Zhang LJ, Zhou HR, Zhang J, et al. Nanoparticle vaccine triggers interferon-gamma production and confers protective immunity against porcine reproductive and respiratory syndrome virus. ACS Nano. 2025;19(1):852–70.
Chen YL, Zhu JH, Wang SQ, Li MH, Sun XK, Liu SY, et al. Modular nano-antigen display platform for pigs induces potent immune responses. ACS Nano. 2024;18(42):29152–77.
Yang D, Su MJ, Guo DH, Zhao FY, Wang MJ, Liu JY, et al. Combination of S1-N-terminal and S1-C-terminal domain antigens targeting double receptor-binding domains bolsters protective immunity of a nanoparticle vaccine against porcine epidemic Diarrhea virus. ACS Nano. 2024;18(19):12235–60.
Curiel TJ, Morris C, Brumlik M, Landry SJ, Finstad K, Nelson A, et al. Peptides identified through phage display direct immunogenic antigen to dendritic cells. J Immunol. 2004;172(12):7425–31.
Trible BR, Kerrigan M, Crossland N, Potter M, Faaberg K, Hesse R, et al. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease. Clin Vaccine Immunol. 2011;18(5):749–57.
Jung BK, Kim HR, Jang H, Chang KS. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice. J Virol Methods. 2020;284: 113928.
Yu C, Li X, Liu JW, Diao WZ, Zhang LC, Xiao Y, et al. Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine. Vaccine. 2016;34(50):6358–66.
Zhou L, Kang RM, Yu JF, Xie B, Chen CY, Li XY, et al. Genetic characterization and pathogenicity of a novel recombined porcine reproductive and respiratory syndrome virus 2 among Nadc30-like, Jxa1-like, and Mlv-like strains. Viruses-Basel. 2018;10(10):551.
Li Y, Jiao D, Jing Y, He Y, Han W, Li Z, et al. Genetic characterization and pathogenicity of a novel recombinant PRRSV from lineage 1, 8 and 3 in China failed to infect MARC-145 cells. Microb Pathog. 2022;165: 105469.
Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Wu Y, Lee LJ, et al. Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. Int J Nanomedicine. 2014;9:679–94.
Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects. World J Virol. 2012;1(1):23–30.
Kim H, Kim HK, Jung JH, Choi YJ, Kim J, Um CG, et al. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods. Virol J. 2011;8:323.
Roca M, Gimeno M, Bruguera S, Segalés J, Díaz I, Galindo-Cardiel IJ, et al. Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine. Vet J. 2012;193(1):92–6.
Song JX, Wang MX, Zhou L, Tian PP, Sun ZY, Sun JR, et al. A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. J Nanobiotechnol. 2023;21(1):424.
Zhang YC, Zhou M, Li YY, Luo ZC, Chen HC, Cui M, et al. Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine. Oncotarget. 2018;9(1):831–41.
Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 2000;1(3):199–205.
Quaratino S, Duddy LP, Londei M. Fully competent dendritic cells as inducers of T cell anergy in autoimmunity. Arthritis Res Ther. 2000;97(20):10911–6.
